
Dakmol-P Tablet
Marketer
Oriel Healthcare Pvt Ltd
Salt Composition
Diclofenac (50mg) + Serratiopeptidase (325mg)
Overview Dakmol-P Tablet
Combiflam-Rx tablets contain a dual-action formula to alleviate pain and inflammation. This medication is indicated for conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, as well as for the relief of muscular aches, back pain, dental pain, and ear/throat discomfort. Combiflam-Rx can be administered with or without food; dosage is determined by the specific condition being treated and its effectiveness. Always follow your physician's prescribed dosage and duration. Exceeding the recommended dose or duration may be harmful. Commonly reported side effects include nausea, vomiting, acid reflux, abdominal pain, dyspepsia, diarrhea, and decreased appetite. Report any persistent or worsening side effects to your doctor, who can suggest mitigation strategies. Prior to commencing treatment, inform your doctor of any history of peptic ulcers, gastrointestinal bleeding, hypertension, or pre-existing cardiac, renal, or hepatic conditions. Complete disclosure of all other medications currently being taken is also crucial, as potential interactions may exist. Consult your physician before using Combiflam-Rx if you are pregnant or breastfeeding. Alcohol consumption should be avoided while taking this medicine due to the risk of increased drowsiness.
Uses of Dakmol-P Tablet
Analgesia
Major Benefits of Dakmol-P Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dakmol-P Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Dakmol-P Tablet:
- Nausea
- Vomiting
- Heartburn
- Stomach pain
- Indigestion
- Diarrhea
- Loss of appetite
How to use Dakmol-P Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dakmol-P Tablets can be consumed with or without food, though consistent timing is recommended.
How Dakmol-P Tablet works:
Dakmol-P Tablets contain Diclofenac and Serratiopeptidase, two active ingredients working synergistically. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), reduces pain and inflammation by inhibiting the production of inflammatory mediators in the central nervous system. Serratiopeptidase, a proteolytic enzyme, facilitates healing by targeting and degrading aberrant proteins within inflamed tissues.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dakmol-P Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Dakmol-P tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is inadvisable. Exceptions may exist in critical medical circumstances where a physician deems the potential benefits outweigh the inherent dangers. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Dakmol-P Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Dakmol-P Tablet side effects. Some users experience headaches, blurred vision, dizziness, or drowsiness; these effects can impact safe driving.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Dakmol-P Tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Dakmol-P Tablets. Dosage modifications may be necessary. Physician consultation is advised. For patients with liver disease taking this medication chronically, routine liver function testing is recommended.
What if you forget to take Dakmol-P Tablet :
Should you forget a Dakmol-P Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed amount.
Facts to Know About Dakmol-P Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
